Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 vs Capecitabine in Inoperable or Recurrent Breast Cancer
NCT00438100Phase 2Completed
- Sponsor
- Japan Breast Cancer Research Network
- Start
- Apr 2008
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in breast cancer, sponsored by Japan Breast Cancer Research Network. Started Apr 2008; status: completed.
02
Drugs
tegafur
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00438100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438100.